Basal-like carcinoma (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Basal-like carcinoma" in English language version.

Last modified: 08:18:52, 22 July 2026 (UTC)

Ref.Un. Ref.Website

Global rank English rank

2925nih.gov

5^th place

2118doi.org

2^nd place

11worldcat.org

4^th place

11adsabs.harvard.edu

14^th place

9^th place

11hdl.handle.net

66^th place

34^th place

11semanticscholar.org

15^th place

8^th place

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

ui.adsabs.harvard.edu

De Brakeleer S, Bogdani M, De Grève J, Decock J, Sermijn E, Bonduelle M, et al. (June 2007). "Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers". Mutation Research. 619 (1–2): 104–12. Bibcode:2007MRFMM.619..104D. doi:10.1016/j.mrfmmm.2007.02.031. PMID 17445839.

doi.org (Global: 2^nd place; English: 2^nd place)

Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, et al. (February 2006). "Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma". Modern Pathology. 19 (2): 264–71. doi:10.1038/modpathol.3800528. PMID 16341146.
Kapp AV, Jeffrey SS, Langerød A, Børresen-Dale AL, Han W, Noh DY, et al. (September 2006). "Discovery and validation of breast cancer subtypes". BMC Genomics. 7 (1): 231. doi:10.1186/1471-2164-7-231. PMC 1574316. PMID 16965636.
Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, et al. (March 2007). "Differences in risk factors for breast cancer molecular subtypes in a population-based study". Cancer Epidemiology, Biomarkers & Prevention. 16 (3): 439–43. doi:10.1158/1055-9965.EPI-06-0806. PMID 17372238.
Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, et al. (May 2008). "Epidemiology of basal-like breast cancer". Breast Cancer Research and Treatment. 109 (1): 123–39. doi:10.1007/s10549-007-9632-6. PMC 2443103. PMID 17578664.
Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, et al. (March 2007). "Differences in risk factors for breast cancer molecular subtypes in a population-based study". Cancer Epidemiology, Biomarkers & Prevention. 16 (3): 439–43. doi:10.1158/1055-9965.EPI-06-0806. PMID 17372238.
Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, et al. (April 2007). "The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes". Clinical Cancer Research. 13 (8): 2329–34. doi:10.1158/1078-0432.CCR-06-1109. PMID 17438091.
Bertucci, F.; Finetti, P.; Birnbaum, D. (2012). "Basal Breast Cancer: A Complex and Deadly Molecular Subtype". Current Molecular Medicine. 12 (1): 96–110. doi:10.2174/156652412798376134. ISSN 1566-5240. PMC 3343384. PMID 22082486.
Rakha EA, Reis-Filho JS, Ellis IO (May 2008). "Basal-like breast cancer: a critical review". Journal of Clinical Oncology. 26 (15): 2568–81. doi:10.1200/JCO.2007.13.1748. PMID 18487574.
Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO (January 2007). "Prognostic markers in triple-negative breast cancer". Cancer. 109 (1): 25–32. doi:10.1002/cncr.22381. PMID 17146782.
Siziopikou KP, Cobleigh M (February 2007). "The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies". Breast. 16 (1): 104–7. doi:10.1016/j.breast.2006.09.003. PMID 17097880.
De Brakeleer S, Bogdani M, De Grève J, Decock J, Sermijn E, Bonduelle M, et al. (June 2007). "Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers". Mutation Research. 619 (1–2): 104–12. Bibcode:2007MRFMM.619..104D. doi:10.1016/j.mrfmmm.2007.02.031. PMID 17445839.
Gauthier ML, Berman HK, Miller C, Kozakeiwicz K, Chew K, Moore D, et al. (November 2007). "Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors". Cancer Cell. 12 (5): 479–91. doi:10.1016/j.ccr.2007.10.017. PMC 3605202. PMID 17996651.
Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, et al. (June 2009). "Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer". Clinical Cancer Research. 15 (11): 3654–62. doi:10.1158/1078-0432.CCR-08-3293. PMC 2887710. PMID 19470724.
Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, et al. (November 2007). "Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression". Journal of Cellular Physiology. 213 (2): 374–83. doi:10.1002/jcp.21223. hdl:10536/DRO/DU:30007175. PMID 17680632.
Yang J, Weinberg RA (June 2008). "Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis". Developmental Cell. 14 (6): 818–29. doi:10.1016/j.devcel.2008.05.009. PMID 18539112.
Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J (February 2008). "Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype". Cancer Research. 68 (4): 989–97. doi:10.1158/0008-5472.CAN-07-2017. PMID 18281472.
Storci G, Sansone P, Trere D, Tavolari S, Taffurelli M, Ceccarelli C, Guarnieri T, Paterini P, Pariali M, Montanaro L, Santini D, Chieco P, Bonafé M (January 2008). "The basal-like breast carcinoma phenotype is regulated by SLUG gene expression". The Journal of Pathology. 214 (1): 25–37. doi:10.1002/path.2254. PMID 17973239. S2CID 25174741.
Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei Y, et al. (October 2007). "Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression". Cancer Research. 67 (19): 9066–76. doi:10.1158/0008-5472.CAN-07-0575. PMC 2570961. PMID 17909010.

hdl.handle.net (Global: 66^th place; English: 34^th place)

Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, et al. (November 2007). "Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression". Journal of Cellular Physiology. 213 (2): 374–83. doi:10.1002/jcp.21223. hdl:10536/DRO/DU:30007175. PMID 17680632.

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, et al. (February 2006). "Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma". Modern Pathology. 19 (2): 264–71. doi:10.1038/modpathol.3800528. PMID 16341146.
Kapp AV, Jeffrey SS, Langerød A, Børresen-Dale AL, Han W, Noh DY, et al. (September 2006). "Discovery and validation of breast cancer subtypes". BMC Genomics. 7 (1): 231. doi:10.1186/1471-2164-7-231. PMC 1574316. PMID 16965636.
Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, et al. (March 2007). "Differences in risk factors for breast cancer molecular subtypes in a population-based study". Cancer Epidemiology, Biomarkers & Prevention. 16 (3): 439–43. doi:10.1158/1055-9965.EPI-06-0806. PMID 17372238.
Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, et al. (May 2008). "Epidemiology of basal-like breast cancer". Breast Cancer Research and Treatment. 109 (1): 123–39. doi:10.1007/s10549-007-9632-6. PMC 2443103. PMID 17578664.
Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, et al. (March 2007). "Differences in risk factors for breast cancer molecular subtypes in a population-based study". Cancer Epidemiology, Biomarkers & Prevention. 16 (3): 439–43. doi:10.1158/1055-9965.EPI-06-0806. PMID 17372238.
Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, et al. (April 2007). "The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes". Clinical Cancer Research. 13 (8): 2329–34. doi:10.1158/1078-0432.CCR-06-1109. PMID 17438091.
Bertucci, F.; Finetti, P.; Birnbaum, D. (2012). "Basal Breast Cancer: A Complex and Deadly Molecular Subtype". Current Molecular Medicine. 12 (1): 96–110. doi:10.2174/156652412798376134. ISSN 1566-5240. PMC 3343384. PMID 22082486.
Rakha EA, Reis-Filho JS, Ellis IO (May 2008). "Basal-like breast cancer: a critical review". Journal of Clinical Oncology. 26 (15): 2568–81. doi:10.1200/JCO.2007.13.1748. PMID 18487574.
Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO (January 2007). "Prognostic markers in triple-negative breast cancer". Cancer. 109 (1): 25–32. doi:10.1002/cncr.22381. PMID 17146782.
Siziopikou KP, Cobleigh M (February 2007). "The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies". Breast. 16 (1): 104–7. doi:10.1016/j.breast.2006.09.003. PMID 17097880.
De Brakeleer S, Bogdani M, De Grève J, Decock J, Sermijn E, Bonduelle M, et al. (June 2007). "Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers". Mutation Research. 619 (1–2): 104–12. Bibcode:2007MRFMM.619..104D. doi:10.1016/j.mrfmmm.2007.02.031. PMID 17445839.
Gauthier ML, Berman HK, Miller C, Kozakeiwicz K, Chew K, Moore D, et al. (November 2007). "Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors". Cancer Cell. 12 (5): 479–91. doi:10.1016/j.ccr.2007.10.017. PMC 3605202. PMID 17996651.
Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, et al. (June 2009). "Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer". Clinical Cancer Research. 15 (11): 3654–62. doi:10.1158/1078-0432.CCR-08-3293. PMC 2887710. PMID 19470724.
Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, et al. (November 2007). "Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression". Journal of Cellular Physiology. 213 (2): 374–83. doi:10.1002/jcp.21223. hdl:10536/DRO/DU:30007175. PMID 17680632.
Yang J, Weinberg RA (June 2008). "Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis". Developmental Cell. 14 (6): 818–29. doi:10.1016/j.devcel.2008.05.009. PMID 18539112.
Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J (February 2008). "Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype". Cancer Research. 68 (4): 989–97. doi:10.1158/0008-5472.CAN-07-2017. PMID 18281472.
Storci G, Sansone P, Trere D, Tavolari S, Taffurelli M, Ceccarelli C, Guarnieri T, Paterini P, Pariali M, Montanaro L, Santini D, Chieco P, Bonafé M (January 2008). "The basal-like breast carcinoma phenotype is regulated by SLUG gene expression". The Journal of Pathology. 214 (1): 25–37. doi:10.1002/path.2254. PMID 17973239. S2CID 25174741.
Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei Y, et al. (October 2007). "Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression". Cancer Research. 67 (19): 9066–76. doi:10.1158/0008-5472.CAN-07-0575. PMC 2570961. PMID 17909010.
Niu RF, Zhang L, Xi GM, Wei XY, Yang Y, Shi YR, et al. (September 2007). "Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma". Journal of Experimental & Clinical Cancer Research. 26 (3): 385–94. PMID 17987801.

ncbi.nlm.nih.gov

Kapp AV, Jeffrey SS, Langerød A, Børresen-Dale AL, Han W, Noh DY, et al. (September 2006). "Discovery and validation of breast cancer subtypes". BMC Genomics. 7 (1): 231. doi:10.1186/1471-2164-7-231. PMC 1574316. PMID 16965636.
Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, et al. (May 2008). "Epidemiology of basal-like breast cancer". Breast Cancer Research and Treatment. 109 (1): 123–39. doi:10.1007/s10549-007-9632-6. PMC 2443103. PMID 17578664.
Bertucci, F.; Finetti, P.; Birnbaum, D. (2012). "Basal Breast Cancer: A Complex and Deadly Molecular Subtype". Current Molecular Medicine. 12 (1): 96–110. doi:10.2174/156652412798376134. ISSN 1566-5240. PMC 3343384. PMID 22082486.
Gauthier ML, Berman HK, Miller C, Kozakeiwicz K, Chew K, Moore D, et al. (November 2007). "Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors". Cancer Cell. 12 (5): 479–91. doi:10.1016/j.ccr.2007.10.017. PMC 3605202. PMID 17996651.
Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, et al. (June 2009). "Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer". Clinical Cancer Research. 15 (11): 3654–62. doi:10.1158/1078-0432.CCR-08-3293. PMC 2887710. PMID 19470724.
Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei Y, et al. (October 2007). "Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression". Cancer Research. 67 (19): 9066–76. doi:10.1158/0008-5472.CAN-07-0575. PMC 2570961. PMID 17909010.

semanticscholar.org (Global: 15^th place; English: 8^th place)

api.semanticscholar.org

Storci G, Sansone P, Trere D, Tavolari S, Taffurelli M, Ceccarelli C, Guarnieri T, Paterini P, Pariali M, Montanaro L, Santini D, Chieco P, Bonafé M (January 2008). "The basal-like breast carcinoma phenotype is regulated by SLUG gene expression". The Journal of Pathology. 214 (1): 25–37. doi:10.1002/path.2254. PMID 17973239. S2CID 25174741.

worldcat.org (Global: 4^th place; English: 4^th place)

search.worldcat.org

Bertucci, F.; Finetti, P.; Birnbaum, D. (2012). "Basal Breast Cancer: A Complex and Deadly Molecular Subtype". Current Molecular Medicine. 12 (1): 96–110. doi:10.2174/156652412798376134. ISSN 1566-5240. PMC 3343384. PMID 22082486.

Basal-like carcinoma (English Wikipedia)

adsabs.harvard.edu (Global: 14th place; English: 9th place)

ui.adsabs.harvard.edu

doi.org (Global: 2nd place; English: 2nd place)

hdl.handle.net (Global: 66th place; English: 34th place)

nih.gov (Global: 5th place; English: 5th place)